Application: Early Cancer Detection Using ccfDNA
Researchers applied MIGHT to liquid biopsy data, focusing on ccfDNA fragmentation patterns (e.g., fragment lengths, positions, and end motifs) to determine which features reliably indicate cancer: Challenge: False Positives Linked to Inflammation A companion study discovered that certain ccfDNA fragmentation signatures thought unique to cancer were also present in individuals with autoimmune (e.g., lupus, scleroderma,…
